A review of chikungunya virus-induced arthralgia: Clinical manifestations, therapeutics, and pathogenesis

Open Rheumatology Journal

Volumn 10, Issue , 2016, Pages 129-140

  Goupil, Brad A ^a   Mores, Christopher N ^a,b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Peru   (Peru)

Author keywords

Acute; Advanced imaging; Arthralgia; Arthritis; Chikungunya virus; Chronic; Pathogenesis; Therapeutics

Indexed keywords

ALPHA INTERFERON; C REACTIVE PROTEIN; CHLOROQUINE; CORTICOSTEROID; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LEFLUNOMIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; SALAZOSULFAPYRIDINE;

ARTHRALGIA; ARTHRITIS; CHIKUNGUNYA VIRUS; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HEADACHE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; LYMPHOCYTOPENIA; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; VIRAL TROPISM; VIREMIA; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

EID: 85008392765     PISSN: None     EISSN: 18743129     Source Type: Journal    
DOI: 10.2174/1874312901610010129     Document Type: Review

References (68)

1. Madariaga M, Ticona E, Resurrecion C. Chikungunya: bending over the Americas and the rest of the world. Braz Soc Infect Dis 2016; 20(1): 91-8. http://dx.doi.org/10.1016/j.bjid.2015.10.004
2. Simon F, Parola P, Grandadam M, et al. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) 2007; 86(3): 123-37. http://dx.doi.org/10.1097/MD/0b013e31806010a5
3. Volpe A, Caramaschi P, Angheben A, et al. Chikungunya outbreakremember the arthropathy. Rheumatology (Oxford) 2006; 45(11): 1449-50. http://dx.doi.org/10.1093/rheumatology/kel275
4. Hawman DW, Stoermer KA, Montgomery SA, et al. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J Virol 2013; 87(24): 13878-88. http://dx.doi.org/10.1128/JVI.02666-13
5. W.H.O. Neglected Tropical Diseases. 2016. Available from: http://www.who.int/neglected_diseases/diseases/en/ Accessed on: March 20
6. CDC. Chikungunya Virus, 2014 final data for the United States. 2016. Available from: http://www.cdc.gov/chikungunya/geo/unitedstates-2014.html. Accessed on: March 20;
7. PAHO. Chikungunya: Statistic Data. 2016. Available from: http://www.paho.org/hq/index.php?option=com_topics&view=readall&cid=5927&Itemid=40931&lang=en. Accessed on: April 15;
8. CDC. Chikungunya Virus, 2015 final data for the United States. 2016. Available from: https://www.cdc.gov/chikungunya/geo/unitedstates-2015.html. Accessed on: July 20;
9. Ali Ou Alla S, Combe B. Arthritis after infection with Chikungunya virus. Best Pract Res Clin Rheumatol 2011; 25(3): 337-46. http://dx.doi.org/10.1016/j.berh.2011.03.005
10. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a re-emerging virus. Lancet 2012; 379(9816): 662-71. http://dx.doi.org/10.1016/S0140-6736(11)60281-X
11. Ahola T, Couderc T, Ng LF, et al. Therapeutics and vaccines against chikungunya virus. Vector Borne Zoonotic Dis 2015; 15(4): 250-7. http://dx.doi.org/10.1089/vbz.2014.1681
12. Thiberville SD, Moyen N, Dupuis-Maguiraga L, et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res 2013; 99(3): 345-70. http://dx.doi.org/10.1016/j.antiviral.2013.06.009
13. Cavrini F, Gaibani P, Pierro AM, Rossini G, Landini MP, Sambri V. Chikungunya: an emerging and spreading arthropod-borne viral disease. J Infect Dev Ctries 2009; 3(10): 744-52.
14. Akahata W, Yang ZY, Andersen H, et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med 2010; 16(3): 334-8. http://dx.doi.org/10.1038/nm.2105
15. Hallengärd D, Kakoulidou M, Lulla A, et al. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. J Virol 2014; 88(5): 2858-66. http://dx.doi.org/10.1128/JVI.03453-13
16. Mallilankaraman K, Shedlock DJ, Bao H, et al. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates. PLoS Negl Trop Dis 2011; 5(1): e928. http://dx.doi.org/10.1371/journal.pntd.0000928
17. Labadie K, Larcher T, Joubert C, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010; 120(3): 894-906. http://dx.doi.org/10.1172/JCI40104
18. Foissac M, Javelle E, Ray S, Guérin B, Simon F. Post-Chikungunya rheumatoid arthritis, Saint Martin. Emerg Infect Dis 2015; 21(3): 530-2. http://dx.doi.org/10.3201/eid2103.141397
19. Sebastian MR, Lodha R, Kabra SK. Chikungunya infection in children. Indian J Pediatr 2009; 76(2): 185-9. http://dx.doi.org/10.1007/s12098-009-0049-6
20. Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum 2008; 58(9): 2921-2. http://dx.doi.org/10.1002/art.23753
21. Calabrese LH. Emerging viral infections and arthritis: the role of the rheumatologist. Nat Clin Pract Rheumatol 2008; 4(1): 2-3. http://dx.doi.org/10.1038/ncprheum0679
22. Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 2012; 6(3): e1446. http://dx.doi.org/10.1371/journal.pntd.0001446
23. Burt F, Chen W, Mahalingam S. Chikungunya virus and arthritic disease. Lancet Infect Dis 2014; 14(9): 789-90. http://dx.doi.org/10.1016/S1473-3099(14)70869-2
24. Jaffar-Bandjee MC, Das T, Hoarau JJ, Krejbich Trotot P, Denizot M, Ribera A, et al. Chikungunya virus takes centre stage in virally induced arthritis: possible cellular and molecular mechanisms to pathogenesis. Microbes Infect/Inst Pasteur 2009; 11(14-15): 1206-8. http://dx.doi.org/10.1016/j.micinf.2009.10.001
25. Higgs S, Ziegler SA. A nonhuman primate model of chikungunya disease. J Clin Invest 2010; 120(3): 657-60. http://dx.doi.org/10.1172/JCI42392
26. Khasnis AA, Schoen RT, Calabrese LH. Emerging viral infections in rheumatic diseases. Semin Arthritis Rheum 2011; 41(2): 236-46. http://dx.doi.org/10.1016/j.semarthrit.2011.01.008
27. Mizuno Y, Kato Y, Takeshita N, et al. Clinical and radiological features of imported chikungunya fever in Japan: a study of six cases at the National Center for Global Health and Medicine. J Infect Chemother 2011; 17(3): 419-23. http://dx.doi.org/10.1007/s10156-010-0124-y
28. Couderc T, Chrétien F, Schilte C, et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 2008; 4(2): e29. http://dx.doi.org/10.1371/journal.ppat.0040029
29. Sissoko D, Malvy D, Ezzedine K, et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 2009; 3(3): e389. http://dx.doi.org/10.1371/journal.pntd.0000389
30. Schilte C, Staikowsky F, Couderc T, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 2013; 7(3): e2137. http://dx.doi.org/10.1371/journal.pntd.0002137
31. Chow A, Her Z, Ong EK, et al. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis 2011; 203(2): 149-57. http://dx.doi.org/10.1093/infdis/jiq042
32. Borgherini G, Poubeau P, Jossaume A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis 2008; 47(4): 469-75. http://dx.doi.org/10.1086/590003
33. Suhrbier A, Jaffar-Bandjee MC, Gasque P. Arthritogenic alphavirusesan overview. Nat Rev Rheumatol 2012; 8(7): 420-9. http://dx.doi.org/10.1038/nrrheum.2012.64
34. Javelle E, Ribera A, Degasne I, Gaüzère BA, Marimoutou C, Simon F. Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 20062012. PLoS Negl Trop Dis 2015; 9(3): e0003603. http://dx.doi.org/10.1371/journal.pntd.0003603
35. Manimunda SP, Vijayachari P, Uppoor R, et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 2010; 104(6): 392-9. http://dx.doi.org/10.1016/j.trstmh.2010.01.011
36. Mathew AJ, Goyal V, George E, Thekkemuriyil DV, Jayakumar B, Chopra A. Rheumatic-musculoskeletal pain and disorders in a naïve group of individuals 15 months following a Chikungunya viral epidemic in south India: a population based observational study. Int J Clin Pract 2011; 65(12): 1306-12. http://dx.doi.org/10.1111/j.1742-1241.2011.02792.x
37. Waymouth HE, Zoutman DE, Towheed TE. Chikungunya-related arthritis: case report and review of the literature. Semin Arthritis Rheum 2013; 43(2): 273-8. http://dx.doi.org/10.1016/j.semarthrit.2013.03.003
38. Hassan R, Rahman MM, Moniruzzaman M, et al. Chikungunya - an emerging infection in Bangladesh: a case series. J Med Case Reports 2014; 8: 67. http://dx.doi.org/10.1186/1752-1947-8-67
39. Roth A, Mercier A, Lepers C, et al. Concurrent outbreaks of dengue, chikungunya and Zika virus infections - an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012-2014. Euro Surveill 2014; 19(41) pii: 20929.
40. Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine 2009; 76(6): 654-7. http://dx.doi.org/10.1016/j.jbspin.2009.08.005
41. Malvy D, Ezzedine K, Mamani-Matsuda M, et al. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis 2009; 9: 200. http://dx.doi.org/10.1186/1471-2334-9-200
42. Chopra A, Anuradha V, Ghorpade R, Saluja M. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect 2012; 140(5): 842-50. http://dx.doi.org/10.1017/S0950268811001300
43. Kularatne SA, Weerasinghe SC, Gihan C, et al. Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a hamlet in sri lanka, in 2007: a longitudinal cohort study. J Trop Med 2012. 2012: 639178.
44. Lui NL, Leong HN, Thumboo J. Polyarthritis in four patients with chikungunya arthritis. Singapore Med J 2012; 53(4): 241-3.
45. Villamil-Gomez WE, Gonzalez-Camargo O, Rodriguez-Ayubi J, Zapata-Serpa D, Rodriguez-Morales AJ. Dengue, chikungunya and Zika coinfection in a patient from Colombia. J Infect Public Health 2016; 9(5): 684-.
46. Schwartz KL, Giga A, Boggild AK. Chikungunya fever in Canada: fever and polyarthritis in a returned traveller. CMAJ 2014; 186(10): 772-4. http://dx.doi.org/10.1503/cmaj.130680
47. Carmona RJ, Shaikh S, Khalidi NA. Chikungunya viral polyarthritis. J Rheumatol 2008; 35(5): 935-6.
48. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM. The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis 2011; 204(1): 115-23. http://dx.doi.org/10.1093/infdis/jiq006
49. Phuklia W, Kasisith J, Modhiran N, et al. Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis. Virus Res 2013; 177(2): 179-88. http://dx.doi.org/10.1016/j.virusres.2013.08.011
50. Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S. Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis 2011; 204(7): 1026-30. http://dx.doi.org/10.1093/infdis/jir470
51. Noret M, Herrero L, Rulli N, et al. Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts. The J Infect Dis 2012; 206(3): 455-7.
52. Chaaitanya IK, Muruganandam N, Sundaram SG, et al. Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. Viral Immunol 2011; 24(4): 265-71. http://dx.doi.org/10.1089/vim.2010.0123
53. Kelvin AA, Banner D, Silvi G, et al. Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis 2011; 5(8): e1279. http://dx.doi.org/10.1371/journal.pntd.0001279
54. McQueen FM. Magnetic resonance imaging in early inflammatory arthritis: what is its role? Rheumatology (Oxford) 2000; 39(7): 700-6. http://dx.doi.org/10.1093/rheumatology/39.7.700
55. Singh SK, Unni SK. Chikungunya virus: host pathogen interaction. Rev Med Virol 2011; 21(2): 78-88. http://dx.doi.org/10.1002/rmv.681
56. Solignat M, Gay B, Higgs S, Briant L, Devaux C. Replication cycle of chikungunya: a re-emerging arbovirus. Virology 2009; 393(2): 183-97. http://dx.doi.org/10.1016/j.virol.2009.07.024
57. Rupp JC, Sokoloski KJ, Gebhart NN, Hardy RW. Alphavirus RNA synthesis and non-structural protein functions. J Gen Virol 2015; 96(9): 2483-500. http://dx.doi.org/10.1099/jgv.0.000249
58. Assuncao-Miranda I, Cruz-Oliveira C, Da Poian AT. Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis. BioMed Res Int 2013. 2013:973516 http://dx.doi.org/10.1155/2013/973516
59. Her Z, Malleret B, Chan M, Ong EK, et al. Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. J Immunol (Baltimore, Md: 1950) 2010; 184(10): 5903-13. http://dx.doi.org/10.4049/jimmunol.0904181
60. Chen W, Foo SS, Sims NA, Herrero LJ, Walsh NC, Mahalingam S. Arthritogenic alphaviruses: new insights into arthritis and bone pathology. Trends Microbiol 2015; 23(1): 35-43. http://dx.doi.org/10.1016/j.tim.2014.09.005
61. Simon F, Javelle E, Cabie A, et al. French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. Med Mal Infect 2015; 45(7): 243-63. http://dx.doi.org/10.1016/j.medmal.2015.05.007
62. Chopra A, Saluja M, Venugopalan A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol 2014; 66(2): 319-26. http://dx.doi.org/10.1002/art.38221
63. Couderc T, Lecuit M. Chikungunya virus pathogenesis: From bedside to bench. Antiviral Res 2015; 121: 120-31. http://dx.doi.org/10.1016/j.antiviral.2015.07.002
64. Ravichandran R, Manian M. Ribavirin therapy for Chikungunya arthritis. J Infect Dev Ctries 2008; 2(2): 140-2. http://dx.doi.org/10.3855/T2.2.140
65. Morrison CR, Plante KS, Heise MT. Chikungunya virus: current perspectives on a reemerging virus. Microbiol Spectr 2016; 4(3) http://dx.doi.org/10.1128/microbiolspec.EI10-0017-2016
66. Chang LJ, Dowd KA, Mendoza FH, et al. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 doseescalation trial. Lancet 2014; 384(9959): 2046-52. http://dx.doi.org/10.1016/S0140-6736(14)61185-5
67. Ramsauer K, Schwameis M, Firbas C, et al. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet Infect Dis 2015; 15(5): 519-27. http://dx.doi.org/10.1016/S1473-3099(15)70043-5
68. Ajene AN, Fischer Walker CL, Black RE. Enteric pathogens and reactive arthritis: a systematic review of Campylobacter, salmonella and Shigella-associated reactive arthritis. J Health Popul Nutr 2013; 31(3): 299-307. http://dx.doi.org/10.3329/jhpn.v31i3.16515